You are here

Clinical Trials: Vascular Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Saturday, July 9, 2016 - 19:00
Conditions:   Peripheral Vascular Disease;   Ischemia;   Diabetic Foot
Interventions:   Biological: Umbilical Cord Mesenchymal Stem Cells;   Biological: saline
Sponsors:   Jie Shen;   Nanfang Hospital of Southern Medical University;   Academy Military Medical Science, China;   The Fifth Affiliated Hospital of Southern Medical University;   Southern Medical University, China
Recruiting - verified July 2016
Posted: Wednesday, July 6, 2016 - 19:00
Condition:   Stroke
Interventions:   Other: Adipose Derived Stem Cells;   Other: Vehicle media
Sponsors:   University Hospital, Grenoble;   European Commission H2020 program;   Univ Grenoble Alpes, France;   Servicio Madrileño de Salud, Madrid, Spain;   Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic;   Servicio Andaluz de Salud, Spain;   University of Glasgow;   University of Eastern Finland;   Etablissement Français du Sang;   University of Tampere;   Histocell SL, Spain;   Medfiles CRO, Finland;   Institut National de la Santé Et de la Recherche Médicale, France;   Hospices Civils de Lyon;   Association groupe ESSEC, France;   NOVADISCOVERY SAS, France;   FINOVATIS, France;   CHU Besancon, France;   Assistance Publique - Hôpitaux de Paris;   CHU Toulouse, France;   CHU Bordeaux, France;   CHU Cote de Nacre, Caen, France;   Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León;   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau;   Servicio de Salud de Castilla La Mancha, Albacete, Spain;   Servizo Galego de Saude, Santiago de Compostela, Spain;   Pirkanmaa Hospital District, Tampere, Finland;   Hospital Vall d'Hebron;   Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting - verified July 2016
Posted: Friday, June 17, 2016 - 19:00
Condition:   Chronic Ischemic Heart Disease
Intervention:   Drug: Bone Marrow Derived Autologous CD133+ Selected Cell Product
Sponsor:   Michael Sekela
Recruiting - verified February 2017
Posted: Wednesday, June 15, 2016 - 19:00
Conditions:   Critical Limb Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease
Interventions:   Other: BGC101 (autologous EnEPC preparation);   Other: Control medium
Sponsors:   BioGenCell Ltd.;   Laniado Hospital
Not yet recruiting - verified June 2016
Posted: Friday, June 3, 2016 - 19:00
Condition:   Stroke
Intervention:   Drug: ADSCs
Sponsor:   Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting - verified June 2016
Posted: Thursday, June 2, 2016 - 19:00
Conditions:   End Stage Renal Disease (ESRD);   Vascular Access Complication
Intervention:   Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
Sponsor:   Mayo Clinic
Not yet recruiting - verified June 2016
Posted: Monday, May 30, 2016 - 19:00
Conditions:   Peripheral Vascular Disease;   Ischemia;   Diabetic Foot
Interventions:   Biological: mesenchymal stem cells;   Biological: saline
Sponsors:   Jie Shen;   Nanfang Hospital of Southern Medical University;   Academy Military Medical Science, China;   The Fifth Affiliated Hospital of Southern Medical University;   Southern Medical University, China
Recruiting - verified June 2016
Posted: Tuesday, May 17, 2016 - 19:00
Condition:   Stroke
Interventions:   Behavioral: Mirror Box Therapy;   Behavioral: Sham Mirror Box Therapy
Sponsors:   Columbia University;   Helen Hayes Hospital
Not yet recruiting - verified May 2016
Posted: Friday, May 13, 2016 - 19:00
Condition:   Diabetic Foot Ulcers
Intervention:   Device: Passive knee extensor machine
Sponsors:   Herlev Hospital;   University of Copenhagen
Recruiting - verified May 2016
Posted: Monday, May 2, 2016 - 19:00
Conditions:   Peripheral Artery Disease;   Vascular Disease;   Critical Limb Ischemia
Intervention:   Device: Injection of cBMA aspirate into the index leg
Sponsors:   Michael Murphy;   Biomet, Inc.
Not yet recruiting - verified August 2016

Pages